These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 17539161)

  • 1. International Commission for Protection against Environmental Mutagens and Carcinogens (ICPEMC).
    Lohman PH
    Environ Health Perspect; 1979 Feb; 28():301-2. PubMed ID: 17539161
    [No Abstract]   [Full Text] [Related]  

  • 2. The International Commission for Protection against Environmental Mutagens and Carcinogens (ICPEMC): the first seven years.
    Jansen JD
    Regul Toxicol Pharmacol; 1984 Jun; 4(2):138-44. PubMed ID: 6739865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Publication No. 15. Alcohol as a mutagenic agent. Report of an ICPEMC expert group.
    Mutat Res; 1987 Nov; 186(3):173-4. PubMed ID: 3670330
    [No Abstract]   [Full Text] [Related]  

  • 4. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques.
    Carrano AV; Natarajan AT
    Mutat Res; 1988 Mar; 204(3):379-406. PubMed ID: 3347212
    [No Abstract]   [Full Text] [Related]  

  • 6. International Commission for Protection against Environmental Mutagens and Carcinogens: ICPEMC news no. 2.
    Sobels FH
    Mutat Res; 1979 Oct; 64(5):357-61. PubMed ID: 514300
    [No Abstract]   [Full Text] [Related]  

  • 7. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Publication No. 12. Inhibitors of mutagenesis and their relevance to carcinogenesis. Report by ICPEMC Expert Group on Antimutagens and Desmutagens.
    Ramel C; Alekperov UK; Ames BN; Kada T; Wattenberg LW
    Mutat Res; 1986 Jul; 168(1):47-65. PubMed ID: 3520303
    [No Abstract]   [Full Text] [Related]  

  • 8. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
    Mutat Res; 1981 May; 86(3):279-304. PubMed ID: 7029262
    [No Abstract]   [Full Text] [Related]  

  • 9. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication No. 5: An evaluation of the genetic toxicity of dichlorvos.
    Ramel C; Drake J; Sugimura T
    Mutat Res; 1980 Nov; 76(3):297-309. PubMed ID: 6782471
    [No Abstract]   [Full Text] [Related]  

  • 10. International Commission for Protection Against Environmental Mutagens and Carcinogens. Spontaneous mutation and its place in risk assessment for chemical mutagens. Report of an ICPEMC Committee.
    Bridges BA; Cole J; Favor J; Glickman BW; Mohrenweiser H; Sankaranarayanan K; Skopek TR
    Mutat Res; 1994 Jan; 304(1):3-11. PubMed ID: 7506356
    [No Abstract]   [Full Text] [Related]  

  • 11. International Commission for Protection Against Environmental Mutagens and Carcinogens. Report of ICPEMC Subcommittee 7/1. The possible involvement of somatic mutations in the development of atherosclerotic plaques.
    Atherosclerosis; 1991 Aug; 89(2-3):255-61. PubMed ID: 1793453
    [No Abstract]   [Full Text] [Related]  

  • 12. International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for combining and comparing short-term genotoxicity test data: preface. A report from ICPEMC Committee 1.
    Brusick DJ; Ashby J; de Serres FJ; Lohman PH; Matsushima T; Matter BE; Mendelsohn ML; Moore DH; Nesnow S; Waters MD
    Mutat Res; 1992 Mar; 266(1):1-6. PubMed ID: 1372961
    [No Abstract]   [Full Text] [Related]  

  • 13. International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9.
    Scott D; Galloway SM; Marshall RR; Ishidate M; Brusick D; Ashby J; Myhr BC
    Mutat Res; 1991 Mar; 257(2):147-205. PubMed ID: 2005937
    [No Abstract]   [Full Text] [Related]  

  • 14. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/4: Critical assessment of the value of in vitro cell transformation for predicting in vivo carcinogenicity of chemicals.
    Brookes P
    Mutat Res; 1981 Mar; 86(2):233-42. PubMed ID: 7266571
    [No Abstract]   [Full Text] [Related]  

  • 15. International Commission for Protection Against Environmental Mutagens and Carcinogens. The possible involvement of somatic mutations in the development of atherosclerotic plaques. Report of ICPEMC Subcommittee 7/1. Conclusions and recommendations.
    Mutat Res; 1990 Nov; 239(3):143-8. PubMed ID: 2233823
    [No Abstract]   [Full Text] [Related]  

  • 16. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Topic No. 1. Are somatic mutations involved in atherosclerosis?
    Bridges BA
    Mutat Res; 1987 Dec; 182(6):301-2. PubMed ID: 3683430
    [No Abstract]   [Full Text] [Related]  

  • 17. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC topic No. 2. Heterozygous effects of multilocus deletions.
    de Serres FJ
    Mutat Res; 1988 Jul; 196(1):95-9. PubMed ID: 3292902
    [No Abstract]   [Full Text] [Related]  

  • 18. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC meeting report no. 3. Is the incidence of Down syndrome increasing?
    Mutat Res; 1986 Dec; 175(4):263-6. PubMed ID: 2946950
    [No Abstract]   [Full Text] [Related]  

  • 19. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 5/4. Perspectives in mutation epidemiology: 4. General principles and considerations.
    Miller JR
    Mutat Res; 1983 Apr; 114(3):425-47. PubMed ID: 6835244
    [No Abstract]   [Full Text] [Related]  

  • 20. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 5/5. Perspectives in mutation epidemiology. 5. Modern medical practice versus environmental mutagens: their possible dysgenic impact.
    Matsunaga E
    Mutat Res; 1983 Apr; 114(3):449-57. PubMed ID: 6835245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.